Description

Torsemide is a loop diuretic that selectively inhibits the Na?/K?/2Cl? co-transporter in the ascending loop of Henle, promoting diuresis and natriuresis. It is commonly used in research models studying fluid retention, congestive heart failure, renal function, and hypertension mechanisms.

This injectable formulation delivers 20mg torsemide per 4ml ampoule, supplied as a pack of 6 ampoules per box, and is manufactured by Nanjing Chengong Pharmaceutical Co., Ltd. with NMPA approval number H20213942.

?? For laboratory and investigational research use only. Not for human or veterinary therapeutic application.

Product Specifications

Mechanism & Research Applications

acts by blocking the Na?/K?/2Cl? transporter in the thick ascending limb of the loop of Henle. This results in increased urinary sodium, chloride, and water excretion, making it valuable in fluid balance studies, renal clearance models, and hypertension or cardiac failure research.

Research applications include:

• Diuresis and renal excretion studies

• Cardiovascular pharmacology

• Experimental models of edema

• Investigation of electrolyte disturbances

• Kidney injury and nephrology research

Torsemide Known Side Effects in Research Models

• Electrolyte imbalance (e.g., hyponatremia, hypokalemia)

• Hypotension

• Dehydration

• Altered renal biomarkers

• Rarely: ototoxicity at high concentrations

Torsemide Safety & Handling Guidelines

• Use Restriction: For laboratory research only; not approved for clinical, diagnostic, or veterinary use.

• Protective Equipment: Use gloves, eye protection, and lab coat.

• Storage: Keep sealed, store below 25°C, protect from light.

• Disposal: Dispose of according to institutional and environmental safety procedures.

Research Use Disclaimer

Torsemide This product is exclusively intended for laboratory research. It is not approved for therapeutic, diagnostic, or veterinary use. Use must comply with applicable research and safety protocols. Improper handling may result in risk.